NEW YORK (GenomeWeb) – A tumultuous global stock market weighed heavily on the shares of companies in the omics life science tools and molecular diagnostics space in August as the GenomeWeb Index fell nearly 8 percent month over month. 

The number of decliners outnumbered the number of gainers 25 to seven in August, and the index also fell more sharply than the Dow Jones Industrial Average and the Nasdaq Composite, both of which fell about 7 percent month over month. It beat the Nasdaq Biotechnology Index, however, which saw an 11 percent contraction in August. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Under a proposed spending bill, the US National Institutes of Health would see an additional $3 billion in funding.

Robert Redfield, the new pick to lead the US Centers for Disease Control and Prevention, has faced criticism for some of his work.

Researchers from the University of Oxford and the University of Sydney sequenced numerous platypus genomes to study their population history.

In Nature this week: sequenced genomes of five additional Neanderthals, and more.